AAAAAA

   
Results: 1-15 |
Results: 15

Authors: BEBOK Z MAZZOCHI C KING S HONG JS SORSCHER EJ
Citation: Z. Bebok et al., EARLY EVENTS IN CFTR BIOGENESIS AND DEGRADATION, The FASEB journal, 12(5), 1998, pp. 3916-3916

Authors: BEBOK Z VENGLARIK CJ PANCZEL Z JILLING T KIRK KL SORSCHER EJ
Citation: Z. Bebok et al., ACTIVATION OF DELTA-F508 CFTR IN AN EPITHELIAL MONOLAYER, American journal of physiology. Cell physiology, 44(2), 1998, pp. 599-607

Authors: BEBOK Z MAZZOCHI C KING SA HONG JS SORSCHER EJ
Citation: Z. Bebok et al., THE MECHANISM UNDERLYING CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR TRANSPORT FROM THE ENDOPLASMIC-RETICULUM TO THE PROTEASOME INCLUDES SEC61-BETA AND A CYTOSOLIC, DEGLYCOSYLATED INTERMEDIARY, The Journal of biological chemistry, 273(45), 1998, pp. 29873-29878

Authors: CLANCY JP HONG JS BEBOK Z KING SA DEMOLOMBE S BEDWELL DM SORSCHER EJ
Citation: Jp. Clancy et al., CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN-1 (NBD-1) AND CFTR TRUNCATED WITHIN NBD-1 TARGET TO THE EPITHELIAL PLASMA-MEMBRANE AND INCREASE ANION PERMEABILITY, Biochemistry (Easton), 37(43), 1998, pp. 15222-15230

Authors: BEDWELL DM KAENJAK A BENOS DJ BEBOK Z BUBIEN JK HONG J TOUSSON A CLANCY JP SORSCHER EJ
Citation: Dm. Bedwell et al., SUPPRESSION OF A CFTR PREMATURE STOP MUTATION IN A BRONCHIAL EPITHELIAL-CELL LINE, Nature medicine, 3(11), 1997, pp. 1280-1284

Authors: CLANCY JP BEBOK Z SORSCHER EJ
Citation: Jp. Clancy et al., PURIFICATION, CHARACTERIZATION, AND EXPRESSION OF CFTR NUCLEOTIDE-BINDING DOMAINS, Journal of bioenergetics and biomembranes, 29(5), 1997, pp. 475-482

Authors: WALKER L KULOMAA MS BEBOK Z PARKER WB ALLAN P LOGAN J HUANG Z REYNOLDS RC KING S SORSCHER EJ
Citation: L. Walker et al., DEVELOPMENT OF DRUG TARGETING BASED ON RECOMBINANT EXPRESSION OF THE CHICKEN AVIDIN GENE, Journal of drug targeting., 4(1), 1996, pp. 41

Authors: DEMOLOMBE S BARO I BEBOK Z CLANCY JP SORSCHER EJ THOMASSOUMARMON A PAVIRANI A ESCANDE D
Citation: S. Demolombe et al., A METHOD FOR THE RAPID DETECTION OF RECOMBINANT CFTR DURING GENE-THERAPY IN CYSTIC-FIBROSIS, Gene therapy, 3(8), 1996, pp. 685-694

Authors: BEBOK Z ABAI AM DONG JY KING SA KIRK KL BERTA G HUGHES BW KRAFT AS BURGESS SW SHAW W FELGNER PL SORSCHER EJ
Citation: Z. Bebok et al., EFFICIENCY OF PLASMID DELIVERY AND EXPRESSION AFTER LIPID-MEDIATED GENE-TRANSFER TO HUMAN-CELLS IN-VITRO, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1462-1469

Authors: LOGAN JJ BEBOK Z WALKER LC PENG SY FELGNER PL SIEGAL GP FRIZZELL RA DONG JY HOWARD M MATALON S LINDSEY JR DUVALL M SORSCHER EJ
Citation: Jj. Logan et al., CATIONIC LIPIDS FOR REPORTER GENE AND CFTR TRANSFER TO RAT PULMONARY EPITHELIUM, Gene therapy, 2(1), 1995, pp. 38-49

Authors: HASTY P ONEAL WK LIU KQ MORRIS AP BEBOK Z SHUMYATSKY GB JILLING T SORSCHER EJ BRADLEY A BEAUDET AL
Citation: P. Hasty et al., SEVERE PHENOTYPE IN MICE WITH TERMINATION MUTATION IN EXON-2 OF CYSTIC-FIBROSIS GENE, Somatic cell and molecular genetics, 21(3), 1995, pp. 177-187

Authors: HUGHES BW WELLS AH BEBOK Z GADI VK GARVER RI PARKER WB SORSCHER EJ
Citation: Bw. Hughes et al., BYSTANDER KILLING OF MELANOMA-CELLS USING THE HUMAN TYROSINASE PROMOTER TO EXPRESS THE ESCHERICHIA-COLI PURINE NUCLEOSIDE PHOSPHORYLASE GENE, Cancer research, 55(15), 1995, pp. 3339-3345

Authors: SORSCHER EJ LOGAN JJ FRIZZELL RA LYRENE RK BEBOK Z DONG JY DUVALL MD FELGNER PL MATALON S WALKER L WIATRAK BJ
Citation: Ej. Sorscher et al., GENE-THERAPY FOR CYSTIC-FIBROSIS USING CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER - A PHASE-I TRIAL OF SAFETY AND EFFICACY IN THE NASAL AIRWAY, Human gene therapy, 5(10), 1994, pp. 1259-1277

Authors: SORSCHER EJ PENG SY BEBOK Z ALLAN PW BENNETT LL PARKER WB
Citation: Ej. Sorscher et al., TUMOR-CELL BYSTANDER KILLING IN COLONIC-CARCINOMA UTILIZING THE ESCHERICHIA COIL DEOD GENE TO GENERATE TOXIC PURINES, Gene therapy, 1(4), 1994, pp. 233-238

Authors: BEBOK Z MARKUS B NEMETH P
Citation: Z. Bebok et al., PROGNOSTIC RELEVANCE OF TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) DETECTED IN BREAST-CANCER TISSUES BY IMMUNOHISTOCHEMISTRY, Breast cancer research and treatment, 29(3), 1994, pp. 229-235
Risultati: 1-15 |